Trials / Unknown
UnknownNCT04691063
The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.
A Multi-center, Randomized, Double-blinded, Phase III Trial of SHR-1316 or Placebo in Combination With Chemo-radiotherapy in Patients With Limited-stage Small-cell Lung Cancer.
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 486 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the efficacy and safety of SHR-1316 in combination with chemo-radiotherapy in patients with LS-SCLC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR-1316; Carboplatin; Etoposide；Radiotherapy | SHR-1316; Carboplatin; Etoposide；Radiotherapy（Part 1 and Part 2） |
| DRUG | Palcebo; Carboplatin; Etoposide；Radiotherapy | Palcebo; Carboplatin; Etoposide；Radiotherapy（Part 2） |
Timeline
- Start date
- 2021-01-22
- Primary completion
- 2025-05-15
- Completion
- 2025-05-15
- First posted
- 2020-12-31
- Last updated
- 2021-02-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04691063. Inclusion in this directory is not an endorsement.